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Background
PCR-based tools for detection of bacterial infections can
considerably shorten the timespan from patient admission
to initiation of targeted antibiotherapy. As culture-based
methods are operator-sensitive and yield lower rates of
identification in longer timespans, dependent on species-
specific growth rates, there is a need for new techniques
leading to rapid identification of the pathogenic agent and
its antimicrobial susceptibility profile.
PLEX-ID (Abbott Molecular Inc, Des Plaines, USA)
ensures bacterial identification in a matter of hours,
directly from clinical specimens, through PCR amplifica-
tion and electrospray ionization-mass spectrometry.
Study hypothesis
Chronic bacterial infections have long been considered an
important issue in clinical practice, particularly when
foreign bodies promote biofilm formation. However, other
mechanisms of bacterial latency such as phenotypic
variants leading to persister cells have also been described
[1], and are increasingly encountered in the clinic. Small
colony variants or persister cells with low metabolic
activity can associate significant delays in laboratory iden-
tification through culture-based techniques. Therefore,
there is a stringent need for the implementation of novel
identification methods.
We aim to perform a prospective study on bi-
compartmental evaluation of bacterial prints in patients
with infectious diseases, within the full range of Carmeli
scores [2]. Serial samples will be collected from normally-
sterile bodily compartments, at three different time-points:
baseline (initiation of antimicrobial therapy), end-of-
treatment, 3-week follow-up. PLEX-ID will be performed
directly from the samples drawn from at least two
normally-sterile bodily compartments, depending on the
primary site of infection. Where two normally-sterile or
tissue samples are not available, blood samples will be
used as control. The decline of bacterial load will be dyna-
mically assessed through semi-quantitative methods and
results will be interpreted based on clinical and paraclini-
cal data on patient evolution, and the degree of adequacy
between the identified antimicrobial sensitivity profile and
the type of therapy administered in clinical practice.
Expected results
We aim to define particular timelines of bacterial interna-
lization or immune clearance and to pinpoint a critical
interval when progression to persistent infection can
occur, and when a clinical intervention would be able to
stop and avert the chronicisation of bacterial infection.
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